RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Leukemia, Published online: 18 November 2019; doi:10.1038/s41375-019-0639-xRIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Source: Leukemia - November 17, 2019 Category: Hematology Authors: Michael Ruzicka Lars M. Koenig Simone Formisano Daniel F. R. Boehmer Binje Vick Eva-M. Heuer Hanna Meinl Lorenz Kocheise Marcus Zeitlh öfler Julia Ahlfeld Sebastian Kobold Stefan Endres Marion Subklewe Peter Duewell Max Schnurr Irmela Jeremias Felix S. L Source Type: research